{"pub_date": "2016-03-13T00:00:00Z", "subsection_name": null, "lead_paragraph": "A spread in share prices suggests that the drug maker\u2019s tax inversion deal with Allergan may not yet be in the bag.", "print_page": "7", "document_type": "article", "byline": {"person": [{"rank": 1, "organization": "", "lastname": "SOMMER", "firstname": "Jeff", "role": "reported"}], "original": "By JEFF SOMMER"}, "multimedia": [{"width": 190, "height": 126, "url": "images/2016/03/13/business/13STRA/13STRA-thumbWide.jpg", "subtype": "wide", "legacy": {"wide": "images/2016/03/13/business/13STRA/13STRA-thumbWide.jpg", "widewidth": "190", "wideheight": "126"}, "type": "image"}, {"width": 600, "height": 375, "url": "images/2016/03/13/business/13STRA/13STRA-articleLarge.jpg", "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlargeheight": "375", "xlarge": "images/2016/03/13/business/13STRA/13STRA-articleLarge.jpg"}, "type": "image"}, {"width": 75, "height": 75, "url": "images/2016/03/13/business/13STRA/13STRA-thumbStandard.jpg", "subtype": "thumbnail", "legacy": {"thumbnail": "images/2016/03/13/business/13STRA/13STRA-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "type": "image"}], "section_name": "Your Money", "headline": {"content_kicker": "Strategies", "print_headline": "Pfizer\u2019s Eager to Go, but the Market Has Doubts", "main": "Pfizer\u2019s Eager to Go, but the Market Has Doubts", "kicker": "Strategies"}, "source": "The New York Times", "blog": [], "word_count": "1217", "web_url": "http://www.nytimes.com/2016/03/13/your-money/pfizers-eager-to-go-but-the-market-has-doubts.html", "slideshow_credits": null, "news_desk": "SundayBusiness", "type_of_material": "News", "snippet": "A spread in share prices suggests that the drug maker\u2019s tax inversion deal with Allergan may not yet be in the bag.", "_id": "56e4634038f0d83a21f5bde6", "abstract": "Jeff Sommer Strategies column asserts investors believe government will obstruct tax inversion merger of Allergan and Pfizer; public and politicians have been calling for end to such mergers. ", "keywords": [{"rank": "1", "name": "organizations", "value": "Allergan Inc", "is_major": "Y"}, {"rank": "2", "name": "organizations", "value": "Pfizer Inc", "is_major": "Y"}, {"rank": "3", "name": "subject", "value": "Corporate Taxes", "is_major": "Y"}, {"rank": "4", "name": "subject", "value": "Taxation", "is_major": "N"}, {"rank": "5", "name": "subject", "value": "Mergers, Acquisitions and Divestitures", "is_major": "N"}, {"rank": "6", "name": "organizations", "value": "Treasury Department", "is_major": "N"}, {"rank": "7", "name": "subject", "value": "Tax Shelters", "is_major": "N"}]}